News
Eli Lilly said on Thursday that its experimental GLP-1 pill helped patients lose 12.4% of their body weight after 72 weeks in ...
While orforglipron succeeded in a Phase 3 trial, its weight loss effects were more modest than investors and analysts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results